The monoamine theory of depression as a target to effective pharmacotherapy
By: Tomasz Karabin, Grazyna Biala and Marta Kruk-Slomka
References
- WHO; 2023. [https://www.who.int/news-room/fact-sheets/detail/depression]
- WHO; 2023. [https://www.who.int/news/item/02-03-2022-covid-19-pandemic-triggers-25-increase-in-prevalence-of-anxiety-and-depression-worldwide]
- Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: From monoamines to the neurogenesis hypothesis model – are we there yet? Behav Brain Res. 2018;34:79-90.
- Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;40(4):219-21.
- Guo P, Chen S, Wang H, Wang Y, Wang J. A systematic analysis on the genes and their interaction underlying the comorbidity of Alzheimer’s disease and major depressive disorder. Front Aging Neurosci. 2022;13:1-17.
- Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association; 2013:155,181.
- Dudek D, Siwek M. Współistnienie chorób somatycznych i depresji. Via Medica. 2007;4(1):17-24.
- Perez-Caballero L, Torres-Sanchez S, Romero-López-Alberca C. et al. Monoaminergic system and depression. Cell Tissue Res. 2019;377:107-13.
- Jiang Y, Zou D, Li Y, Gu S, Dong J, Ma X, et al. Monoamine neurotransmitters control basic emotions and affect major depressive disorders. Pharmaceuticals (Basel).2022;15(10):1203.
- Ślifirski G, Król M, Turło J. 5-HT Receptors and the development of new antidepressants. Int J Mol Sci. 2021;22(16):9015.
- Pandarakalam JP. Challenges of treatment-resistant depression. Psychiatr Danub. 2018;30(3):273-84.
- Sabella D. Antidepressant medications. Am J Med. 2018;118(9):52-9.
- Fritze, S, Spanagel, R, Noori, HR. Adaptive dynamics of the 5-HT systems following chronic administration of selective serotonin reuptake inhibitors: a meta-analysis. J Neurochem. 2017;142:747-55.
- Drugbank. [https://go.drugbank.com/]
- Schwasinger-Schmidt TE, Macaluso M. Other Antidepressants. Handb Exp Pharmacol. 2018;250:325-55.
- Miller JJ. Rx evolution: An ununified model of MDD and pharmacological paradigms. Psychiatr Times. 2023;40(2):1-7
Language: English
Page range: 108 - 113
Submitted on: Mar 29, 2023
Accepted on: Jun 7, 2023
Published online: Jun 30, 2023
Published in print: Jun 1, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Related subjects:
© 2023 Tomasz Karabin, Grazyna Biala, Marta Kruk-Slomka, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.